A Phase III Study of the Safety and Efficacy of Entecavir in Pediatric Patients With Chronic Hepatitis B Virus Infection

NCT01079806 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

180

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis B Virus, Pediatric

Interventions

DRUG: Entecavir
DRUG: Placebo

Sponsor

Bristol-Myers Squibb